bluebird bio, Inc. Operating Expenses
bluebird bio, Inc. reported Operating Expenses of $176.20 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-02-21
- bluebird bio, Inc. operating expenses for the quarter ending 2018-12-31 was $176.20M, a 45.70% increase year-over-year.
- bluebird bio, Inc. operating expenses for the quarter ending 2018-09-30 was $161.35M, a 89.00% increase year-over-year.
- bluebird bio, Inc. operating expenses for the quarter ending 2018-06-30 was $156.47M, a 85.08% increase year-over-year.
- bluebird bio, Inc. operating expenses for the quarter ending 2018-03-31 was $132.59M, a 72.76% increase year-over-year.
- bluebird bio, Inc. operating expenses for fiscal 2018 was $626.60M, a 70.46% increase from fiscal 2017.
- bluebird bio, Inc. operating expenses for fiscal 2017 was $367.59M, a 34.17% increase from fiscal 2016.
- bluebird bio, Inc. operating expenses for fiscal 2016 was $273.99M, a 49.62% increase from fiscal 2015.
- bluebird bio, Inc. operating expenses for fiscal 2015 was $183.12M, a 112.81% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2018-12-31 | $176.20M 10-K · filed 2019-02-21 | $337.55M derived: sum of 2 quarters · filed 2019-02-21 | $494.02M derived: sum of 3 quarters · filed 2019-02-21 | $626.60M 10-K · filed 2019-02-21 |
| 2018-09-30 | $161.35M 10-K · filed 2019-02-21 | $317.81M derived: sum of 2 quarters · filed 2019-02-21 | $450.40M 10-Q · filed 2018-11-01 | $571.34M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | $156.47M 10-K · filed 2019-02-21 | $289.05M 10-Q · filed 2018-08-02 | $409.99M derived: sum of 3 quarters · filed 2019-02-21 | $495.36M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | $132.59M 10-K · filed 2019-02-21 | $253.53M derived: sum of 2 quarters · filed 2019-02-21 | $338.89M derived: sum of 3 quarters · filed 2019-02-21 | $423.43M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $120.94M 10-K · filed 2019-02-21 | $206.31M derived: sum of 2 quarters · filed 2019-02-21 | $290.85M derived: sum of 3 quarters · filed 2019-02-21 | $367.59M 10-K · filed 2019-02-21 |
| 2017-09-30 | $85.37M 10-K · filed 2019-02-21 | $169.91M derived: sum of 2 quarters · filed 2019-02-21 | $246.65M 10-Q · filed 2018-11-01 | $320.54M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $84.54M 10-K · filed 2019-02-21 | $161.28M 10-Q · filed 2018-08-02 | $235.17M derived: sum of 3 quarters · filed 2019-02-21 | $314.86M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $76.75M 10-K · filed 2019-02-21 | $150.63M derived: sum of 2 quarters · filed 2019-02-21 | $230.32M derived: sum of 3 quarters · filed 2019-02-21 | $291.85M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $73.89M 10-K · filed 2018-02-21 | $153.58M derived: sum of 2 quarters · filed 2018-02-21 | $215.11M derived: sum of 3 quarters · filed 2018-02-21 | $273.99M 10-K · filed 2019-02-21 |
| 2016-09-30 | $79.69M 10-K · filed 2018-02-21 | $141.22M derived: sum of 2 quarters · filed 2018-02-21 | $200.10M 10-Q · filed 2017-11-01 | $250.53M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | $61.53M 10-K · filed 2018-02-21 | $120.41M 10-Q · filed 2017-08-02 | $170.84M derived: sum of 3 quarters · filed 2018-02-21 | $215.29M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $58.88M 10-K · filed 2018-02-21 | $109.31M derived: sum of 2 quarters · filed 2018-02-21 | $153.76M derived: sum of 3 quarters · filed 2018-02-21 | $210.72M derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | $50.43M 10-K · filed 2017-02-22 | $94.88M derived: sum of 2 quarters · filed 2017-02-22 | $151.85M derived: sum of 3 quarters · filed 2017-02-22 | $183.12M 10-K · filed 2018-02-21 |
| 2015-09-30 | $44.45M 10-K · filed 2017-02-22 | $101.41M derived: sum of 2 quarters · filed 2017-02-22 | $132.69M 10-Q · filed 2016-11-02 | $158.68M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $56.96M 10-K · filed 2017-02-22 | $88.23M 10-Q · filed 2016-08-03 | $114.23M derived: sum of 3 quarters · filed 2017-02-22 | $137.61M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $31.27M 10-K · filed 2017-02-22 | $57.27M derived: sum of 2 quarters · filed 2017-02-22 | $80.64M derived: sum of 3 quarters · filed 2017-02-22 | $100.31M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $26.00M 10-K · filed 2016-02-25 | $49.38M derived: sum of 2 quarters · filed 2016-02-25 | $69.04M derived: sum of 3 quarters · filed 2016-02-25 | $86.05M 10-K · filed 2017-02-22 |
| 2014-09-30 | $23.38M 10-K · filed 2016-02-25 | $43.04M derived: sum of 2 quarters · filed 2016-02-25 | $60.05M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $19.67M 10-K · filed 2016-02-25 | $36.67M derived: sum of 2 quarters · filed 2016-02-25 | ||
| 2014-03-31 | $17.00M 10-K · filed 2016-02-25 | |||
| 2013-12-31 | $45.13M 10-K · filed 2016-02-25 |